Clinical Trial Update: A Study of NH280105 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 study of NH280105 in healthy adult participants has completed. The trial evaluated safety and pharmacokinetics in the context of Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NH280105

Snippet

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd. | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED